{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:45:12Z","timestamp":1778341512828,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21529-x","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T13:20:14Z","timestamp":1763472014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk factors of adverse pregnancy outcomes in patients with immunoglobulin A nephropathy"],"prefix":"10.1038","volume":"15","author":[{"given":"Yuko","family":"Asano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Fuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"21529_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10157-012-0746-8","volume":"17","author":"H Sugiyama","year":"2013","unstructured":"Sugiyama, H. et al. Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010. Clin. Exp. Nephrol. 17, 155\u2013173 (2013).","journal-title":"Clin. Exp. Nephrol."},{"key":"21529_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/ndt\/gfq665","volume":"26","author":"A McGrogan","year":"2011","unstructured":"McGrogan, A., Franssen, C. F. M. & De Vries, C. S. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol. Dial. Transplant. 26, 414\u2013430 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"21529_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/ndt\/gfp620","volume":"25","author":"F Pesce","year":"2010","unstructured":"Pesce, F. & Schena, F. P. Worldwide distribution of glomerular diseases: the role of renal biopsy registries. Nephrol. Dial. Transplant. 25, 334\u2013336 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"21529_CR4","doi-asserted-by":"publisher","first-page":"11151","DOI":"10.1038\/s41598-020-68087-y","volume":"10","author":"T Moriyama","year":"2020","unstructured":"Moriyama, T. et al. Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids\/immunosuppressors. Sci. Rep. 10, 11151 (2020).","journal-title":"Sci. Rep."},{"key":"21529_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s10157-015-1177-0","volume":"20","author":"H Komatsu","year":"2016","unstructured":"Komatsu, H. et al. Clinical manifestations of Henoch-Sch\u00f6nlein purpura nephritis and IgA nephropathy: comparative analysis of data from the Japan Renal Biopsy Registry (J-RBR). Clin. Exp. Nephrol. 20, 552\u2013560 (2016).","journal-title":"Clin. Exp. Nephrol."},{"key":"21529_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1681\/ASN.0000000000000053","volume":"34","author":"J Tangren","year":"2023","unstructured":"Tangren, J. et al. Pre-pregnancy eGFR and the risk of adverse maternal and fetal outcomes: A population-based study. JASN 34, 656\u2013667 (2023).","journal-title":"JASN"},{"key":"21529_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1053\/j.ajkd.2014.11.019","volume":"66","author":"J Kendrick","year":"2015","unstructured":"Kendrick, J. et al. Kidney disease and maternal and fetal outcomes in pregnancy. Am. J. Kidney Dis. 66, 55\u201359 (2015).","journal-title":"Am. J. Kidney Dis."},{"key":"21529_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000320730","volume":"32","author":"A Shimizu","year":"2010","unstructured":"Shimizu, A. et al. Effect of kidney disease stage on pregnancy and delivery outcomes among patients with immunoglobulin A nephropathy. Am. J. Nephrol. 32, 456\u2013461 (2010).","journal-title":"Am. J. Nephrol."},{"key":"21529_CR9","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.2169\/internalmedicine.54.5071","volume":"54","author":"A Shimizu","year":"2015","unstructured":"Shimizu, A. et al. Effect of pregnancy and delivery on the renal function and the prognosis of patients with chronic kidney disease stage 3 caused by immunoglobulin A nephropathy. Intern. Med. 54, 3127\u20133132 (2015).","journal-title":"Intern. Med."},{"key":"21529_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/ndt\/gfx061","volume":"33","author":"S Park","year":"2018","unstructured":"Park, S. et al. Pregnancy in women with immunoglobulin A nephropathy: are obstetrical complications associated with renal prognosis?. Nephrol. Dial. Transplant. 33, 459\u2013465 (2018).","journal-title":"Nephrol. Dial. Transplant."},{"key":"21529_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1053\/j.ajkd.2017.01.043","volume":"70","author":"X Su","year":"2017","unstructured":"Su, X. et al. Pregnancy and kidney outcomes in patients with IgA nephropathy: A cohort study. Am. J. Kidney Dis. 70, 262\u2013269 (2017).","journal-title":"Am. J. Kidney Dis."},{"key":"21529_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1053\/j.ajkd.2010.03.033","volume":"56","author":"M Limardo","year":"2010","unstructured":"Limardo, M. et al. Pregnancy and progression of IgA nephropathy: Results of an Italian multicenter study. Am. J. Kidney Dis. 56, 506\u2013512 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"21529_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000496410","volume":"49","author":"F Wang","year":"2019","unstructured":"Wang, F., Lu, J.-D., Zhu, Y., Wang, T.-T. & Xue, J. Renal outcomes of pregnant patients with immunoglobulin A nephropathy: A systematic review and meta-analysis. Am. J. Nephrol. 49, 214\u2013224 (2019).","journal-title":"Am. J. Nephrol."},{"key":"21529_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000446354","volume":"44","author":"Y Liu","year":"2016","unstructured":"Liu, Y., Ma, X., Zheng, J., Liu, X. & Yan, T. A systematic review and meta-analysis of kidney and pregnancy outcomes in IgA nephropathy. Am. J. Nephrol. 44, 187\u2013193 (2016).","journal-title":"Am. J. Nephrol."},{"key":"21529_CR15","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/ki.1991.320","volume":"40","author":"S Abe","year":"1991","unstructured":"Abe, S. Pregnancy in IgA nephropathy. Kidney Int. 40, 1098\u20131102 (1991).","journal-title":"Kidney Int."},{"key":"21529_CR16","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s40620-021-00979-2","volume":"34","author":"S Jarrick","year":"2021","unstructured":"Jarrick, S. et al. Pregnancy outcomes in women with immunoglobulin A nephropathy: a nationwide population-based cohort study. J. Nephrol. 34, 1591\u20131598 (2021).","journal-title":"J. Nephrol."},{"key":"21529_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/jcm7080212","volume":"7","author":"GB Piccoli","year":"2018","unstructured":"Piccoli, G. B. et al. A systematic review on materno-foetal outcomes in pregnant women with IgA nephropathy: A case of \u201clate-maternal\u201d preeclampsia?. JCM 7, 212 (2018).","journal-title":"JCM"},{"key":"21529_CR18","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1681\/ASN.2010040355","volume":"22","author":"F Berthoux","year":"2011","unstructured":"Berthoux, F. et al. Predicting the risk for dialysis or death in IgA nephropathy. J. Am. Soc. Nephrol. 22, 752\u2013761 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"21529_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/pds.4444","volume":"27","author":"T Ishikawa","year":"2018","unstructured":"Ishikawa, T. et al. Development of algorithms to determine the onset of pregnancy and delivery date using health care administrative data in a university hospital in Japan. Pharmacoepidemiol. Drug Saf. 27, 751\u2013762 (2018).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"21529_CR20","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s10157-021-02095-8","volume":"25","author":"H Suzuki","year":"2021","unstructured":"Suzuki, H. et al. A digest from evidence-based clinical practice guideline for IgA nephropathy 2020. Clin. Exp. Nephrol. 25, 1269\u20131276 (2021).","journal-title":"Clin. Exp. Nephrol."},{"key":"21529_CR21","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1007\/s10157-023-02396-0","volume":"27","author":"K Matsuzaki","year":"2023","unstructured":"Matsuzaki, K. et al. Current treatment status of IgA nephropathy in Japan: a questionnaire survey. Clin. Exp. Nephrol. 27, 1032\u20131041 (2023).","journal-title":"Clin. Exp. Nephrol."},{"key":"21529_CR22","doi-asserted-by":"publisher","first-page":"21299","DOI":"10.1038\/s41598-021-00670-3","volume":"11","author":"J Dvo\u0159\u00e1k","year":"2021","unstructured":"Dvo\u0159\u00e1k, J. et al. Chronic kidney disease and pregnancy outcomes. Sci. Rep. 11, 21299 (2021).","journal-title":"Sci. Rep."},{"key":"21529_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejogrb.2016.07.512","volume":"204","author":"J Bharti","year":"2016","unstructured":"Bharti, J. et al. Pregnancy with chronic kidney disease: maternal and fetal outcome. Eur. J. Obstet. Gynecol. Reprod. Biol. 204, 83\u201387 (2016).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"21529_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1056\/NEJM199809033391004","volume":"339","author":"BM Sibai","year":"1998","unstructured":"Sibai, B. M., Klebanoff, M. & Paul, R. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. N. Engl. J. Med. 339, 667\u2013671 (1998).","journal-title":"N. Engl. J. Med."},{"key":"21529_CR25","doi-asserted-by":"publisher","first-page":"e018494","DOI":"10.1161\/JAHA.120.018494","volume":"10","author":"SY Al Khalaf","year":"2021","unstructured":"Al Khalaf, S. Y. et al. Impact of chronic hypertension and antihypertensive treatment on adverse perinatal outcomes: Systematic review and meta-analysis. JAHA 10, e018494 (2021).","journal-title":"JAHA"},{"key":"21529_CR26","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/HYPERTENSIONAHA.107.107565","volume":"51","author":"LC Chappell","year":"2008","unstructured":"Chappell, L. C. et al. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: A prospective study. Hypertension 51, 1002\u20131009 (2008).","journal-title":"Hypertension"},{"key":"21529_CR27","unstructured":"Japanese Society of Nephrology. Clinical Practice guidelines for the management of pregnancy in kidney disease patients. (Accessed 8 July 2025). https:\/\/cdn.jsn.or.jp\/data\/jsn-pregnancy.pdf. (2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21529-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21529-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21529-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T02:02:27Z","timestamp":1763863347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21529-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21529"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21529-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40427"}}